Covid impact on Truscreen

Jun 2, 2021 | Latest News

31.5.21 Cervical cancer technology company Truscreen Group has released its preliminary unaudited financial results for the year ended 31 March 2021. The results reflect the impact of COVID-19 and show a 12% reduction in product revenues YOY, a 23% reduction in total revenues that included a lower research and development refund offset claim from the […]

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

[adrotate banner="4"]

Covid impact on Truscreen

You need an active membership to keep reading

either log in via the form below or click here to subscribe

Your Advertisement Here

Your Advertisement Here